SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-028402
Filing Date
2018-11-07
Accepted
2018-11-07 16:05:44
Documents
2
Period of Report
2018-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1559
2 EX-24 DOCUMENT attachment1.htm EX-24 4916
  Complete submission text file 0000899243-18-028402.txt   7948
Mailing Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080
Business Address
HAUMANN BRETT K (Reporting) CIK: 0001607733 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37519 | Film No.: 181166295

Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Issuer) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations